Corton Capital Inc. Entrada Therapeutics, Inc. Transaction History
Corton Capital Inc.
- $196 Million
- Q3 2024
A detailed history of Corton Capital Inc. transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 57,849 shares of TRDA stock, worth $1.1 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
57,849
Previous 54,973
5.23%
Holding current value
$1.1 Million
Previous $783,000
18.14%
% of portfolio
0.47%
Previous 0.43%
Shares
6 transactions
Others Institutions Holding TRDA
# of Institutions
101Shares Held
28.1MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$92.6 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$84.3 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$83.9 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$58.1 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$32.6 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $597M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...